Choline alfoscerate

DRUG4 trials

Sponsors

Seoul National University Hospital, Daewoong Pharmaceutical Co. LTD., Seoul National University Bundang Hospital, Chong Kun Dang Pharmaceutical

Conditions

Alzheimer DiseaseCognitive ImpairmentDiabetes Mellitus, Type 2Mild Cognitive ImpairmentStroke

Phase 3

The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes

CompletedNCT03249259

Seoul National University Bundang HospitalDiabetes Mellitus, Type 2

Start: 2016-03-10End: 2019-09-30Updated: 2019-10-08

Phase 4

The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no Dementia

CompletedNCT01363648

Seoul National University HospitalCognitive Impairment, Stroke

Start: 2010-11-30End: 2013-03-31Updated: 2013-10-14

A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients

Daewoong Pharmaceutical Co. LTD.Alzheimer Disease

Start: 2015-07-31Target: 128Updated: 2016-11-02

A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment

Chong Kun Dang PharmaceuticalMild Cognitive Impairment

Start: 2021-09-30End: 2024-11-30Target: 418Updated: 2021-09-20